The mission of the Biomarker Collaborative is to educate patients and all stakeholders on the importance of molecular profiling and the value of introducing patients to their respective biomarker support group upon diagnosis.
Key Activities
1) Educating patients and clinicians on the critical importance of biomarker testing throughout the patient journey: upon diagnosis, upon resistance, and at each pivot point. 2) Educating stakeholders on the important role that biomarker support groups can and should play to support the patient. 3) Public policy advocacy work at the U.S. state and federal level in addition to international work including, a) protecting and enhancing the drug development pipeline; b) maintaining and enhancing patient access to treatments; c) clinical trial advocacy; d) supporting initiatives for coverage of biomarker testing and molecular profiling, and, e) encouraging a stronger patient and care partner voice vis a vis health technology assessment bodies across the globe.